Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Estetrol, a pregnancy-specific human steroid, prevents and suppresses mammary tumor growth in a rat model.
Climacteric : the journal of the International Menopause Society·2017
Presence of intratumoral stem cells in breast cancer patients with or without BRCA germline mutations.
Current cancer drug targets·2011
Factors influencing the identification rate of the sentinel node in breast cancer.
European journal of cancer care·2011
Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
Climacteric : the journal of the International Menopause Society·2011
Proteomics in mammary cancer research.
European journal of gynaecological oncology·2010
[Gynecologic urology].
Gynakologische Rundschau·1991
[Does fetal reaction to vibro-acoustic stimulation depend on its activity state?].
Gynakologische Rundschau·1991
[Vulvar cancer. Bern university gynecologic clinic patients treated 1978 to 1987].
Gynakologische Rundschau·1991
[Acceptance and subjective well-being with a norgestimate combination pill].
Gynakologische Rundschau·1991
[Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause].
Gynakologische Rundschau·1991
[Is there a correlation in the frequent association of neuroblastoma-fetal malformations?].
Gynakologische Rundschau·1991
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026